EMR - NYSE

Emerson Electric Co.

EMR·NYSE

$140.88

-0.81%

IndustrialsIndustrial - Machinery

Emerson Electric Co., a technology and engineering company, provides various solutions for customers in industrial, commercial, and residential markets in the Americas, Asia, the Middle East, Africa, and Europe. The company operates through Automation Solutions, and Commercial & Residential Solutions segments. The Automation Solutions segment offers measurement and analytical instrumentation, industrial valves and equipment, and process control software and systems. It serves oil and gas, refining, chemicals, power generation, life sciences, food and beverage, automotive, pulp and paper, metals and mining, and municipal water supplies markets. The Commercial & Residential Solutions segment offers residential and commercial heating and air conditioning products, such as reciprocating and scroll compressors; system protector and flow control devices; standard, programmable, and Wi-Fi thermostats; monitoring equipment and electronic controls for gas and electric heating systems; gas valves for furnaces and water heaters; ignition systems for furnaces; sensors and thermistors for home appliances; and temperature sensors and controls. It also provides reciprocating, scroll, and screw compressors; precision flow controls; system diagnostics and controls; and environmental control systems. In addition, this segment offers air conditioning, refrigeration, and lighting control technologies, as well as facility design and product management, site commissioning, facility monitoring, and energy modeling services; tools for professionals and homeowners; and appliance solutions. Emerson Electric Co. was incorporated in 1890 and is headquartered in Saint Louis, Missouri.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$78.91B

EPS4.0700

P/E Ratio34.61

Earnings Date08/05/2026

41.96B

Assets

-5%

3Y+18.0%

5Y+83.0%

10Y+93.0%

21.67B

Total Liabilities

29%

3Y+12.0%

5Y+50.0%

10Y+53.0%

20.30B

Total Equity

-26%

3Y+24.0%

5Y+140.0%

10Y+166.0%

Emerson Electric Co. Funding & Solvency Profile

EMR · NYSE

Current Assets

Cash & Cash Equivalents1.54B

Net Receivables3.10B

Inventory2.21B

Other Current Assets1.73B

Total Current Assets9 B

Non-Current Assets

Property, Plant & Equipment3.51B

Goodwill & Intangible Assets27.65B

Long-Term Investments676.00M

Other Non-Current Assets1.47B

Total Non-Current Assets6 B

Total Assets

41.96B

Financial Health Analysis

Current Ratio

0.88x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.07x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-1214000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

20% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Negative working capital with limited cash reserves requires immediate attention—potential liquidity crisis if not addressed promptly.

Emerson Electric Co. Balance Sheet

EMR • NYSE

Emerson Electric Co. Balance Sheet	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009	Sep 2008	Sep 2007	Sep 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	1.5B	3.6B	8.1B	1.8B	2.4B	3.3B	1.5B	1.1B	3.1B	3.2B	3.1B	3.1B	3.3B	2.4B	2.1B	1.6B	1.6B	1.8B	1B	810M
Cash & Short-Term Investments	1.5B	3.6B	8.1B	1.8B	2.4B	3.3B	1.5B	1.1B	3.1B	3.2B	3.1B	3.1B	3.3B	2.4B	2.1B	1.6B	1.6B	1.8B	1B	810M
Net Receivables	3.1B	2.9B	2.5B	2.3B	3B	2.8B	3B	3B	3.1B	2.7B	2.9B	5B	4.8B	5B	4.5B	4B	3.6B	4.6B	4.3B	3.7B
Accounts Receivables	3.1B	2.9B	2.5B	2.3B	3B	2.8B	3B	3.3B	3.1B	2.7B	2.9B	5B	4.8B	5B	4.5B	4B	3.6B	4.6B	4.3B	3.7B
Inventory	2.2B	2.2B	2B	1.7B	2.1B	1.9B	1.9B	1.8B	1.7B	1.2B	1.8B	2.1B	1.9B	2.1B	2.1B	2.1B	1.9B	2.3B	2.2B	2.2B
Other Current Assets	1.7B	1.5B	1.2B	2.7B	1.1B	761M	780M	369M	422M	2.9B	2.9B	642M	1B	651M	691M	677M	615M	588M	570M	582M
Total Current Assets	8.6B	10.2B	13.8B	8.5B	8.4B	8.8B	7.1B	6.6B	8.3B	10B	10B	10.9B	11B	10.1B	9.3B	8.4B	7.7B	9.3B	8.1B	7.3B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	3.5B	3.5B	2.4B	2.2B	3.7B	3.7B	3.6B	3.6B	3.3B	2.9B	2.9B	3.8B	3.6B	3.5B	3.4B	3.3B	3.5B	3.5B	3.4B	3.2B
Goodwill	18.2B	18.1B	14.5B	13.9B	7.7B	6.7B	6.5B	6.5B	5.3B	3.9B	6.7B	7.2B	7.5B	8B	8.8B	8.7B	7.1B	6.6B	6.4B	6B
Intangible Assets	9.5B	10.4B	6.3B	6.6B	2.9B	2.5B	2.6B	2.8B	1.9B	902M	1.5B	1.7B	1.7B	1.8B	2B	2.2B	0.0	0.0	0.0	633M
Goodwill & Intangible Assets	27.7B	28.5B	20.7B	20.5B	10.6B	9.2B	9.2B	9.2B	7.2B	4.8B	8.2B	8.9B	9.2B	9.9B	10.7B	10.8B	7.1B	6.6B	6.4B	6.6B
Long-Term Investments	676M	0.0	3.3B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	79M	64M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	1.5B	2B	2.6B	4.4B	1.9B	1.2B	565M	1B	810M	4B	4.3B	637M	926M	319M	339M	387M	388M	1.6B	1.8B	1.9B
Total Non-Current Assets	33.4B	34.1B	28.9B	27.2B	16.3B	14.1B	13.4B	13.8B	11.3B	11.8B	12B	13.3B	13.7B	13.7B	14.5B	14.5B	12.1B	11.7B	11.6B	11.3B
Total Assets	42B	44.2B	42.7B	35.7B	24.7B	22.9B	20.5B	20.4B	19.6B	21.7B	22.1B	24.2B	24.7B	23.8B	23.9B	22.8B	19.8B	21B	19.7B	18.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.5B	1.9B	1.3B	1.3B	2.1B	1.7B	1.9B	1.9B	1.8B	1.7B	1.6B	3.1B	2.9B	2.9B	2.8B	2.5B	2B	2.9B	2.5B	2.3B
Accounts Payable	1.4B	1.3B	1.3B	1.3B	2.1B	1.7B	1.9B	1.9B	1.8B	1.5B	1.5B	3B	2.7B	2.8B	2.7B	2.4B	1.9B	2.7B	2.5B	2.3B
Other Payables	130M	587M	0.0	0.0	0.0	0.0	0.0	0.0	65M	180M	87M	162M	129M	128M	139M	96M	52M	173M	0.0	0.0
Accrued Expenses	1.5B	1.3B	3.2B	3B	3.3B	2.9B	2.7B	2.6B	2.3B	2.1B	2.1B	2.9B	3.2B	2.7B	2.8B	2.9B	2.4B	2.5B	2.3B	1.9B
Short Term Debt	4.8B	532M	547M	2.1B	872M	1.2B	1.4B	1.6B	862M	2.6B	2.6B	2.5B	1.6B	1.5B	877M	480M	577M	1.2B	404M	898M
Capital Lease Obligations (Current)	138M	158M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64M	65M	180M	86M	162M	129M	128M	139M	96M	52M	0.0	0.0	0.0
Deferred Revenue	1B	1B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	830M	788M	0.0	1.3B	0.0	0.0	0.0	0.0	0.0	1.6B	1.6B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	304M	238M
Total Current Liabilities	9.8B	5.7B	5B	7.8B	6.2B	5.8B	6B	6.2B	5B	8B	7.8B	8.5B	7.6B	7.1B	6.5B	5.8B	5B	6.6B	5.5B	5.4B
NON-CURRENT LIABILITIES
Long Term Debt	8.3B	7.2B	7.6B	8.3B	5.8B	6.3B	4.3B	3.1B	3.8B	4.1B	4.3B	3.6B	4.1B	3.8B	4.3B	4.6B	4B	3.3B	3.4B	3.1B
Deferred Tax Liabilities (Non-Current)	1.8B	2.1B	2B	1.7B	711M	261M	327M	484M	425M	210M	270M	572M	823M	592M	361M	0.0	0.0	533M	519M	724M
Other Non-Current Liabilities	1.2B	1.2B	1.1B	1.3B	1.6B	1.7B	1.6B	1.6B	1.6B	1.8B	1.6B	1.4B	1.5B	1.9B	2.2B	2.5B	2.1B	1.5B	1.3B	1.1B
Total Non-Current Liabilities	11.9B	11B	11.1B	11.6B	8.5B	8.7B	6.2B	5.2B	5.8B	6.1B	6.2B	5.6B	6.4B	6.2B	6.8B	7B	6.1B	5.4B	5.2B	5B
Capital Lease Obligations	643M	669M	404M	312M	413M	373M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	21.7B	16.7B	16.1B	19.4B	14.8B	14.4B	12.2B	11.4B	10.8B	14.1B	14B	14B	14B	13.4B	13.3B	12.9B	11.2B	11.7B	10.7B	10.3B
SHAREHOLDERS' EQUITY
Treasury Stock	-20.1B	-19B	-18.7B	-16.7B	-16.3B	-15.9B	-15.1B	-13.9B	-13B	-12.8B	-12.3B	-9.8B	-9B	-7.9B	-7.1B	-6.3B	-6.3B	-5.7B	-4.7B	-3.9B
Common Stock	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	477M	238M
Additional Paid-In Capital	85M	169M	62M	57M	522M	470M	393M	348M	297M	205M	170M	161M	352M	324M	317M	192M	157M	146M	31M	161M
Retained Earnings	40.6B	40.8B	40.1B	28.1B	26B	25B	24.2B	23.1B	22B	21.7B	21.3B	19.9B	18.9B	18.1B	17.3B	15.9B	14.7B	14B	12.5B	11.3B
Accumulated Other Comprehensive Income/Loss	-821M	-868M	-1.3B	-1.5B	-872M	-1.6B	-1.7B	-1B	-1B	-2B	-1.6B	-575M	-189M	-731M	-562M	-426M	-496M	141M	382M	306M
Total Stockholders' Equity	20.3B	21.6B	20.7B	10.4B	9.9B	8.4B	8.2B	8.9B	8.7B	7.6B	8.1B	10.1B	10.6B	10.3B	10.4B	9.8B	8.6B	9.1B	8.8B	8.2B
Total Equity	20.3B	27.5B	26.6B	16.3B	9.9B	8.4B	8.3B	9B	8.8B	7.6B	8.1B	10.2B	10.7B	10.4B	10.6B	10B	8.7B	9.1B	9B	8.3B
Minority Interest	16M	5.9B	5.9B	6B	40M	42M	40M	43M	52M	50M	47M	48M	133M	147M	152M	160M	0.0	188M	191M	176M
SUMMARY
Total Liabilities & Equity	42B	44.2B	42.7B	35.7B	24.7B	22.9B	20.5B	20.4B	19.6B	21.7B	22.1B	24.2B	24.7B	23.8B	23.9B	22.8B	19.8B	21B	19.7B	18.7B
Total Investments	676M	0.0	3.3B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	13.8B	8.4B	8.6B	10.7B	7.1B	7.9B	5.7B	4.8B	4.7B	6.6B	6.8B	6B	5.6B	5.3B	5.2B	5.1B	4.6B	4.5B	3.8B	4B
Net Debt	12.2B	4.8B	510M	8.9B	4.7B	4.5B	4.2B	3.7B	1.6B	3.5B	3.8B	2.9B	2.4B	2.9B	3.1B	3.5B	3B	2.7B	2.8B	3.2B
Shares Outstanding	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173	561,863,173

SEC Filings

EMR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 13, 2026	February 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 06, 2026	February 03, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	February 03, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 03, 2026	February 03, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	December 12, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 20, 2025	November 20, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 14, 2025	November 13, 2025	2025	View Filing
10-K 10-K 2025 FY FY	November 10, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 610 filings

Related Guides

Blog Categories

Continue your EMR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.